Evidence map›Paper›PMID 41463366›Full record

ReviewBiomolecules2025

Integrative Regulatory Networks of MicroRNA-483: Unveiling Its Systematic Role in Human Diseases and Clinical Implications.

Jiatong Xu, Shupeng Luxu, Hsi-Yuan Huang, Yang-Chi-Dung Lin, Hsien-Da Huang

Abstract readReview
In one paragraph

Review in Biomolecules, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jiatong XuSchool of Medicine, The Chinese University of Hong Kong, Shenzhen 518172, China.ORCID 0000-0002-4557-3414
Shupeng LuxuSchool of Medicine, The Chinese University of Hong Kong, Shenzhen 518172, China.
Hsi-Yuan HuangSchool of Medicine, The Chinese University of Hong Kong, Shenzhen 518172, China.ORCID 0000-0001-8453-4939
Yang-Chi-Dung LinSchool of Medicine, The Chinese University of Hong Kong, Shenzhen 518172, China.ORCID 0000-0003-2436-4602
Hsien-Da HuangSchool of Medicine, The Chinese University of Hong Kong, Shenzhen 518172, China.

Funding

2023 The Second Affiliated Hospital of the Chinese University of Hong Kong, Shenzhen Joint Fund Project HUUF-MS-2023082023 The Second Affiliated Hospital of the Chinese University of Hong Kong, Shenzhen Joint Fund Project HUUF-MS-202309Guangdong Science and Technology Program 2024A0505050001Guangdong Science and Technology Program 2024A0505050002Guangdong Young Scholar Development Fund of Shenzhen Ganghong Group Co., Ltd. 2021E0005Guangdong Young Scholar Development Fund of Shenzhen Ganghong Group Co., Ltd. 2022E0035Phase III Government Matching Fund of Shenzhen Ganghong Group Co., Ltd. 2023E0012Shenzhen Science and Technology Program JCYJ20220530143615035Shenzhen Science and Technology Program JCYJ20250604141041017Shenzhen Science and Technology Program JCYJ20250604141235046the National Natural Science Foundation of China 82471825the Shenzhen-Hong Kong Jointly Funded Project Category A; SGDX20230116093201002the Warshel Institute for Computational Biology funding from Shenzhen City and Longgang District LGKCSDPT2025001
6 · The paper itself

Abstract

MicroRNA-483 regulates multiple human disease categories, spanning oncology, cardiopulmonary, metabolic, immune, neurological, and musculoskeletal pathologies. We integrate experimentally validated interactions from 146 studies to construct a comprehensive regulatory network, encompassing transcription factors, long non-coding RNAs, circular RNAs, and messenger RNA targets. Our analysis reveals that miR-483 promotes tumorigenesis by suppressing tumor-suppressive checkpoints, yet it protects cardiopulmonary, metabolic, and neurological tissues from pathological injury. This functional duality arises from tissue-specific modulation of shared signaling pathways, particularly TGF-β and MAPK cascades, which function as the core hubs driving its context-dependent activity across six disease categories. By mapping miR-483 regulatory circuits across multiple diseases, we define the molecular determinants of its context-dependent activity. These findings establish miR-483 as both a diagnostic biomarker and a therapeutic target whose function is dictated by cellular context.

Indexed as

Gene Regulatory NetworksMicroRNAsHumansNeoplasmsRNA, CircularSignal TransductionMicroRNAsMIRN483 microRNA, humanRNA, CircularbiomarkerceRNAmiRNA-483regulatory networktherapeutic targettranscription factor

Identifiers

PMID41463366
PMCPMC12730746

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.